Variables | Vaccine 10 μg | Vaccine 40 μg | p |
---|---|---|---|
No. patients (%) | 39 (49.3) | 40 (50.7) | - |
Gender male – No. (%) | 27 (69.2) | 29 (72.5) | 0.749 |
Mean age (years ± s.d.) | 35.6 ± 8.12 | 34.1 ± 7.6 | 0.378 |
HIV exposure – No. (%) | |||
Heterosexual | 18 (45%) | 16 (41%) | 0.721 |
Homo or bisexual | 22 (55%) | 23 (59%) | |
Diagnosis of HIV (months ± s.d.) | 40.6 ± 35.4 | 40.2 ± 32.65 | 0.960 |
Mean CD4 count (cel/mm3 ± s.d.) | 245 ± 217.9 | 225.45 ± 189.7 | 0.671 |
CD4 cel/mm3 / No. (%) | |||
< 200 | 20 (51.3%) | 21 (52.5%) | 0.914 |
≥ 200 | 19 (48.8%) | 19 (47.5%) | |
Viral load (copies/mL) | 75,187 ± 153,305 | 67,335 ± 112,742 | 0.811 |
Viral load (copies/mL) – No. (%) | |||
≤ 400 | 6 (20%) | 9 (25%) | 0.860 |
400 – ≤ 20,000 | 11 (36.6%) | 11 (30.6%) | |
≥ 20,000 | 13 (43.3%) | 16 (44.4%) | |
AIDS-defining illness – No. (%) | 17 (43.6) | 10 (25) | 0.082 |
Treatment with HAART* – No. (%) | 22 (56.4) | 29 (72.5) | 0.135 |
PI | 20 (51.2) | 23 (57.5) | |
NNRTI | 1 (2.6) | 4 (10) | |
PI + NNRTI or 3 NRTI | 1 (2.6) | 2 (5) |